Business Context and Reporting Period
This Form 8-K was filed by Greatbatch, Inc. on April 13, 2006. The report discloses the entry into a material definitive agreement with SORIN/ELA BIOMEDICA CRM and ELA MEDICAL SAS (collectively "SORIN/ELA").
Key Financial Metrics
The filing text does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity figures. The document focuses exclusively on the terms of a new supply agreement.
Material Changes
The primary material change is the execution of a supply agreement on April 13, 2006. Under this agreement, Greatbatch, Inc. will supply SORIN/ELA with assembled headers, batteries, capacitors, feedthroughs, filtered feedthroughs, cases, coated components, and miscellaneous machined or molded pieces for use in medical devices. Pricing is agreed upon but subject to adjustment based on volumes and other factors.
Outlook and Management Commentary
- Agreement Term: The initial term of the agreement runs through December 31, 2010.
- Future Disclosure: Management intends to file a copy of the full agreement with the Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2006.
- Risks and Contingencies: The filing does not explicitly list risks or contingencies, though pricing adjustments based on volume are noted as a variable.
Key Facts for Investor Verification
- Verify the specific volume commitments and pricing adjustment mechanisms in the full agreement once filed in the Form 10-Q.
- Confirm the expected revenue contribution from SORIN/ELA relative to the company's total medical device component sales.
- Monitor the expiration date of the initial term (December 31, 2010) for potential renewal or renegotiation events.